Screener
Maravai LifeSciences Holdings, Inc. MRVI Restructuring Charges
Restructuring Charges at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestructuringCharges.
The source filing: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001823239-26-000059
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Selling, general and administrative | 32,070 | 38,715 | 61,162 | 78,279 |
| Research and development | 3,702 | 4,882 | 7,591 | 9,770 |
| Goodwill impairment | — | 30,449 | — | 42,884 |
| Restructuring | (33) | — | 2,845 | — |
| Total operating expenses | 35,739 | 74,046 | 71,598 | 130,933 |
| Loss from operations | (15,089) | (66,278) | (17,247) | (115,440) |
| Other income (expense): | ||||
| Interest expense | (4,809) | (6,815) | (10,558) | (13,593) |
Item 1. Financial Statements
FAQ
- What is Maravai LifeSciences Holdings, Inc.'s restructuring charges?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported restructuring charges of -$33K in Q2 2026.
- What does restructuring charges mean?
- One-time costs from reorganizing operations, including employee severance, facility closure costs, contract termination fees, and asset relocation expenses.
Ask your AI about Maravai LifeSciences Holdings, Inc.'s restructuring charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude